KEGG enrichment analysis indicated that luteolin against NSCLC via the PI3K-Akt signaling pathway, proteoglycans in cancer, NF-kappa B signaling pathway, and transcriptional misregulation in cancer. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.